| Patents for C07D 417 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group (62,773) |
|---|
| 09/13/2006 | EP1218358B1 Therapeutic quinazoline compounds |
| 09/13/2006 | EP1087951B9 Carbon substituted aminothiazole inhibitors of cyclin dependent kinases |
| 09/13/2006 | EP0917462B1 Cell adhesion inhibitors |
| 09/13/2006 | CN1832947A Thiazole derivatives as npy antagonists |
| 09/13/2006 | CN1832946A Process for producing imide compound |
| 09/13/2006 | CN1832941A Halogenated quinazolinyl nitrofurans as antibacterial agents |
| 09/13/2006 | CN1832934A Benzoxazepine-based compound |
| 09/13/2006 | CN1832932A Biaryl heterocyclic compounds and methods of making and using the same |
| 09/13/2006 | CN1832930A Amide derivative |
| 09/13/2006 | CN1832927A Novel gamma-secretase inhibitors |
| 09/13/2006 | CN1832925A New p2x7 receptor avtagonists and their use |
| 09/13/2006 | CN1832921A Tetrahydrocarbazole derivatives and their pharmaceutical use |
| 09/13/2006 | CN1832740A Indol-5 sulfonamide derivatives, their preparation and their use 5-ht-6 as modulators |
| 09/13/2006 | CN1830977A Novel process for preparation of 2-aminothiazolecarboxamide derivatives |
| 09/13/2006 | CN1274686C Suitable industrialized method of preparing Lamivudine |
| 09/13/2006 | CN1274675C Novel cyclobutene diketone compound and its producing process, and pharmaceutical composition containing the same compound |
| 09/13/2006 | CN1274305C Pharmaceutical composition with combined active agents and methods for using the same |
| 09/12/2006 | US7105701 Multibinding compounds for agonists for phenolic derivatives for adrenergic receptors with carriers |
| 09/12/2006 | US7105682 Substituted amine derivatives and methods of use |
| 09/12/2006 | US7105671 2-Substituted phenyl,3-polar ring,N-heroaromatic propion-amides, e.g., 1-(2-(3,4-Dichlorophenyl)-3-(tetrahydro-furan-2-yl)-propionyl)-3- methylurea; antidiabetic agents; increase the flux of glucose metabolism in beta-cells and hepatocytes |
| 09/12/2006 | US7105670 Intermediates useful in the preparation of diaminothiazoles |
| 09/12/2006 | US7105667 Fused heterocyclic compounds and use thereof |
| 09/12/2006 | US7105564 7-(3-{[5-(Pyrrole-1-sulfonyl)-thiophene-2-carbonyl]-amino}-bicyclo[2.2.1]hept-2-yl)-hept-5-enoic acid; thromboxane A2 receptor and a prostaglandin D2 receptor; for all of eosinophilic infiltration, advance of respiratory anaphylaxis and respiratory contraction |
| 09/12/2006 | US7105554 Benzylidene thiazolidinediones and their use as antimycotic agents |
| 09/12/2006 | US7105553 Thiazolyl amide derivatives |
| 09/12/2006 | US7105550 2,4-disubstituted thiazolyl derivatives |
| 09/12/2006 | US7105544 N-{3-[1-(3-{[BIS(4-FLUOROPHENYL)ACETYL]AMINO}PROPYL)-4-PIPERIDINYL]PHENYL}-2-METHYLPROPANAMIDE; antagonists for melanin concentrating hormone-1 (MCH1) receptors; treating depression, anxiety, obesity |
| 09/12/2006 | US7105537 For enhancing bone formation; for therapy of diseases or disorders associated with abnormal bone or mineral homeostasis |
| 09/12/2006 | US7105529 A novel compound for treating alopecia induced by cancer chemotherapy or radiotherapy |
| 09/12/2006 | US7105519 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/12/2006 | US7105517 N-{4-[2-(1-Dimethylamino-ethylimino)-4-phenyl-thiazol-5-yl]-pyrimidin-2-yl}-N-phenyl-amine; fungicides against infestation by phytopathogenic organisms, nematodes, insects, fungi, bacteria, viruses |
| 09/12/2006 | US7105515 Such as N-[3-(2-diethylaminoethyl)-1H-indol-5-yl]-5-chloro-3-methylbenzo[b]thiophene-2-sulphonamide for treating anxiety, depression, cognitive memory disorders and senile dementia, psychosis, infant hyperkinesia (ADHD, attention deficit/hyperactivity disorder) |
| 09/12/2006 | US7105514 2-methyl-3-(4,5,7-trifluorobenzothiazol-2-yl)methyl-indole-N-acetic; acidinhibit aldose reductase; treating diabetes mellitus, including, diabetic cataracts, retinopathy, nephropathy, and neuropathy |
| 09/12/2006 | US7105513 Cardiovascular disorders; strokes; hypotensive agents |
| 09/12/2006 | US7105512 Having anti- inflammatory effect, which is less irritant, which has high safety and storage stability |
| 09/12/2006 | US7105509 Benzodiazepine derivatives as APP modulators |
| 09/12/2006 | US7105508 Integrin receptors antagonists |
| 09/12/2006 | US7105507 Cyclohexane derivatives and their use as therapeutic agents |
| 09/12/2006 | US7105505 Benzimidazole derivatives useful as histamine H3 antagonists |
| 09/12/2006 | US7105503 Pyrazole compounds |
| 09/12/2006 | CA2235986C Inhibitors of protein isoprenyl transferases |
| 09/12/2006 | CA2167004C Agent for treating mental disorders associated with cerebrovascular disorders |
| 09/12/2006 | CA2140929C Hydroxyethylamino sulfonamides useful as retroviral protease inhibitors |
| 09/11/2006 | CA2500667A1 Preparation of acid addition salts of ziprasidone and intermediates thereof by solid phase-gas phase reactions |
| 09/08/2006 | WO2006094235A1 Fused heterocyclic compounds and their use as sirtuin modulators |
| 09/08/2006 | WO2006093801A1 Thiadiazine derivatives useful as anti-infective agents |
| 09/08/2006 | WO2006093339A1 Use of cinnamoyl compound |
| 09/08/2006 | WO2006093247A1 NOVEL AMINOPYRIDINE COMPOUND WITH Syk INHIBITORY ACTIVITY |
| 09/08/2006 | WO2006092608A1 Tricyclic derivatives of azetidine and pyrrole with antibacterial activity |
| 09/08/2006 | WO2006092599A2 Pyrrole derivatives as dna gyrase and topoisomerase inhibitors |
| 09/08/2006 | WO2006092574A1 Indolylamino quinazoline derivatives as antitumor agents |
| 09/08/2006 | WO2006092573A1 Indazolylamino qionazoline derivatives as antitumor agents |
| 09/08/2006 | WO2006092395A1 9-amino-acridine derivatives and their use for eliminating misfolded proteins |
| 09/08/2006 | WO2005086700A3 Hiv integrase inhibitors |
| 09/08/2006 | WO2005035551A3 Inhibitors of proteins that bind phosphorylated molecules |
| 09/08/2006 | CA2600287A1 Use of cinnamoyl compound |
| 09/08/2006 | CA2599992A1 Acridine and quinoline dervatives as sirtuin modulators |
| 09/08/2006 | CA2599987A1 Fused heterocyclic compounds and their use as sirtuin modulators |
| 09/08/2006 | CA2599544A1 Novel aminopyridine compound with syk inhibitory activity |
| 09/07/2006 | US20060199964 preparation of 6-haloalkyl-3-nicotinic acid esters and also to novel enamine intermediates |
| 09/07/2006 | US20060199960 e.g. 6-Methyl-3-(pyridin-3-ylamino)-pyridine-2-carboxylic acid (4-methyl-thiazol-2-yl)-amide; metabotropic glutamate receptor antagonists (mGluR); central nervous system disorders, antidepressant, anxiolytc agent; psychosis, epilepsy, schizophrenia, Alzheimer's disease, cognitive disorders |
| 09/07/2006 | US20060199958 Process and intermediates for the preparation of pyrrolidine carboxylic acids |
| 09/07/2006 | US20060199949 Cyanine dyes as labeling reagents for detection of biological and other materials by luminescence methods |
| 09/07/2006 | US20060199851 Novel compounds that are useful for improving pharmacokinetics |
| 09/07/2006 | US20060199844 Inhibitors of raf-kinase; Hyperproliferative disorders |
| 09/07/2006 | US20060199830 N-(4-(4-methylthiazol-5-yl) pyrimidin-2-yl)-N-phenylamines as antiproliferative compounds |
| 09/07/2006 | US20060199828 Pyrazine-2-carboxyamide derivatives |
| 09/07/2006 | US20060199827 Inhibitors of macrophage migration inhibitory factor and methods for identifying the same |
| 09/07/2006 | US20060199826 Cyclopropane compounds and pharmaceutical use thereof |
| 09/07/2006 | US20060199825 4-Aminating a 4-chloro-2-hydroxy-3-nitrodihydroquinoline with a N-(hetero)cyclylpiperazine, and alkylating the remaining amine group in the quinoline ring to produce a 4-(4-(hetero)cyclylpiperazinyl)-3-nitro-1-alkyldihydroquinolinone |
| 09/07/2006 | US20060199824 Treating or preventing pain, UI, an ulcer, IBD, IBS, an addictive disorder, Parkinson's disease, parkinsonism, anxiety, epilepsy, stroke, a seizure, a pruritic condition, psychosis, a cognitive disorder, a memory deficit, restricted brain function, Huntington's chorea, amyotrophic lateral sclerosis |
| 09/07/2006 | US20060199822 Bis-sulfonamide hydroxyethylamino retroviral protease inhibitors |
| 09/07/2006 | US20060199818 Inhibiting the activity of a 5-hydroxytryptamine 2A by administering a N-heterocyclyl (preferably 1,3-dioxan-5-yl)-4-[(N-substituted)(hetero)arylamino]piperidine in which the N-substituant is arylalkanoyl, arylthioalkanoyl, arylalkylaminocarbonyl or arylalkylaminothiocarbonyl group |
| 09/07/2006 | US20060199813 Neurodegenerative diseases, psychological disorders; e.g. 1-[3-(4-Butyl-piperidin-1-yl)-propyl]-1,2,3,4-tetrahydroquinoline |
| 09/07/2006 | US20060199810 Neurodegenerative diseases, psychological disorders; e.g. 1-[3-(4-Butyl-piperidin-1-yl)-propyl]-1,2,3,4-tetrahydro-quinoline |
| 09/07/2006 | US20060199804 ATP-competitive inhibitors of serine/threonine kinase (mTOR); antifungal agents, anticancer agents, autoimmune diseases, inflammation, bone loss, bowel disorders, hepatic fibrosis/necrosis, rheumatoid arthritis, psoriasis |
| 09/07/2006 | US20060199799 Benzimidazolidinone derivatives as muscarinic agents |
| 09/07/2006 | US20060199242 Stain compounds containing fluorophore and reducible quenching unit; for detection of bacterial cells, monitoring electron transport chain function of bacterial cells, monitoring oxidation state of non-biological systems, and assaying the effectiveness of antibacterial or antimicrobial agents; kits |
| 09/07/2006 | DE102005009909A1 Verbindungen geeignet zur Beseitigung fehlgefalteter Proteine Compounds suitable for the removal of misfolded proteins |
| 09/06/2006 | EP1698696A1 Target protein of antidiabetic agent and novel antidiabetic agent insuful corresponding thereto |
| 09/06/2006 | EP1698628A1 Hydroxypyrimidinone derivative having hiv integrase inhibitory activity |
| 09/06/2006 | EP1698627A1 Pyrazole compounds useful as protein kinase inhibitors |
| 09/06/2006 | EP1698626A1 Amidopyrazole derivative |
| 09/06/2006 | EP1698624A1 Phenylpropanoic acid derivatives |
| 09/06/2006 | EP1698375A1 Azetidine ring compounds and drugs comprising the same |
| 09/06/2006 | EP1697355A2 Amidino compounds as cysteine protease inhibitors |
| 09/06/2006 | EP1697354A1 Isothiazole dioxides as cxc- and cc- chemokine receptor ligands |
| 09/06/2006 | EP1697352A2 4-azole substituted imidazole compositions useful as inhibitors or c-met receptor tyrosine kinase |
| 09/06/2006 | EP1697351A1 2,6-bisheteroaryl-4-aminopyrimidines as adenosine receptor antagonists |
| 09/06/2006 | EP1697348A1 Hiv protease inhibiting compounds |
| 09/06/2006 | EP1697344A2 Hiv protease inhibiting compounds |
| 09/06/2006 | EP1697334A1 Heterocyclic substituted indane derivatives and related compounds for the treatment of schizophrenia |
| 09/06/2006 | EP1697333A1 (3,4-disubstituted)propanoic carboxylates as s1p (edg) receptor agonists |
| 09/06/2006 | EP1697327A1 Insecticidal spiroindane derivatives |
| 09/06/2006 | EP1697320A1 A synthetic methodology for the reductive alkylation at the c-3 position of indoles |
| 09/06/2006 | EP1697312A2 Hydroxamic acid esters and pharmaceutical use thereof |
| 09/06/2006 | EP1696924A1 Acidic quinoline derivatives and their use for the prevention and/or treatment of hyperglycaemia-related pathologies |
| 09/06/2006 | EP1696919A2 3-cycloalkylaminopyrrolidine derivatives as modulators of chemokine receptors |
| 09/06/2006 | EP1696915A1 Benzenesulfonylamino-pyridin-2-yl derivatives and related compounds as inhibitors of 11-beta-hydroxysteroid dehydrogenase type 1 (11-beta-hsd-1) for the treatment of diabetes and obesity |
| 09/06/2006 | EP1458697B1 Biphenylmethyl-thiazolidinediones and analogues and their use as ppar-gamma activators |